Anti aging pill. Rezv – the innovative anti-aging pill. Why wait for an anti-aging drug? researchers interviewed on cbs.The serious search for an anti-aging pill. |
A human anti-aging pill in ten years | beyond the beyondAnti aging pill. only cost a fraction of the latter). Given all this, one might expect governments to be showering scientists with huge grants to tackle aging, and that researchers would be eager to cut across traditional disciplinary boundaries to help make the discipline of applied gerontology a reality. And you might also think that there would be a booming "grass roots" movement among the general population championing the importance of utilizing science to help aging populations enjoy more health. Sadly, none of this is the case. If we really want to significantly improve the health prospects of the majority of humans alive today, and if we really want to help prevent the most prevalent diseases of the 21st century, and if we really want to invest in the economy of the future then we must get behind aging research. Last night 60 Minutes aired this excellent video on the advances being made with resveratrol and similar sirtuin activating compounds. Cheers, Colin posted by Colin Farrelly at 10:18 AM << Home About Me Name: Colin Farrelly Location: Kingston, Ontario, Canada I am Associate Professor and Queen's National Scholar in the Dept of Political Studies at Queen's University. View my complete profile Blogs I Like Bioethics Blog Crooked Timber Leiter Reports Legal Theory Blog Left2Right Lessig Blog Norm Blog Chicago Law Faculty Blog Thoughts Arguments and Rants Brad DeLong Daniel Drezner Virtue Theory Discussion Forum (Notes on) Politics, Theory & Photography Jacob T. Levy Ethxblog Public Reason Blog Fight Aging Alliance for Aging Research Longevity Science Skeptical Adaptation![]() |
Anti aging pillOl could reduce the impact of a high fat diet, increase stamina two fold and significantly extend lifespan of mice. Skeptics have long claimed that aging is too complex to be regulated by a small number of genes, though Sinclair and other leading longevity scientists such as Leonard Guarente of the Massachusetts Institute of Technology and Cynthia Kenyon of the University of California at San Francisco keep refining and supporting their argument that it is. Investors have believed the Sirtris story enough to pony up $103 million in private rounds and $63 million in an IPO last May. Sirtris' stock today has risen as much as 6 percent—roughly twice the rise in the S&P 500 index. The current paper does not target longevity specifically, but demonstrates that Sirtris's pills may slow a major disease of aging, diabetes type II, which afflicts 18 million Americans. The pills improved insulin sensitivity, lowered plasma glucose levels, and increased the function of mitochondria, the powerhouse of the cell that is associated with healthy and long-living cells. "In this study, these novel drug candidates improved insulin sensitivity, which could unlock a new approach to treating type 2 diabetes," Christoph Westphal said in an email. Westphal is C.E.O. and a cofounder of Sirtris, and a co-author of the study. The lead author is Jill Milne, senior director of biology at Sirtris. This past May, the company started human trials using a super-potent version of resveratrol, and so far the drug has passed muster. The synthetic compounds are both more potent and more stable chemically |
|
anti aging pill News:
anti aging pill© 2005 Best Anti aging doctors portland or anti aging doctors portland or contacts: info@yahoo.com |